This inventor holds 1 USPTO granted patent. Top assignees: Ionis Pharmaceuticals, Inc., The University of Texas System. Active years: 2019.
Company Filing History:
1 out of 288 
1 out of 5,630 
Years Active: 2019
Title: Jacqueline T Hecht: Innovator in Nucleic Acid Modulation
Introduction
Jacqueline T Hecht is a notable inventor based in Houston, TX (US). She has made significant contributions to the field of biotechnology, particularly in the modulation of nucleic acids. Her work has implications for understanding and treating conditions related to cartilage and growth plate development.
Latest Patents
Jacqueline T Hecht holds 1 patent for her invention titled "Compounds and methods for the modulation of COMP." This patent focuses on methods that result in the modulation of the activity or expression of target nucleic acids in cells. Specifically, it addresses nucleic acids that encode cartilage oligomeric matrix protein, which is crucial for cartilage health and development.
Career Highlights
Throughout her career, Jacqueline has worked with esteemed organizations such as the University of Texas System and Ionis Pharmaceuticals, Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Jacqueline has collaborated with talented individuals, including Shuling Guo and Punit P Seth. These partnerships have enhanced her research and expanded the impact of her innovations.
Conclusion
Jacqueline T Hecht's work in nucleic acid modulation exemplifies the importance of innovation in biotechnology. Her contributions continue to influence the understanding of cartilage-related conditions and highlight the potential for future advancements in this area.